SUN PHARMACEUTICAL IND L vs WINDLAS BIOTECH LIMITED
A side-by-side comparison of SUN PHARMACEUTICAL IND L (SUNPHARMA) and WINDLAS BIOTECH LIMITED (WINDLAS) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
On the numbers, SUN PHARMACEUTICAL IND L leads SUNPHARMA vs WINDLAS on 9 of 14 metrics (1 tied). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).
Valuation
How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
How efficiently each company turns capital and sales into profit. Higher is better.
Growth
Three-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- + ["Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 34.1%"]
- − ["The company has delivered a poor sales growth of 11.8% over past five years."]
- + ["Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 19.8%", "Promoter holding has increased by 1.32% over last quarter.", "Company's working capital requirements have reduced from 21.4 days to 14.4 days"]
- − ["Company has a low return on equity of 12.8% over last 3 years."]
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.